Visit other SMART + STRONG sites:
AIDSMEDSREAL HEALTHTU SALUD
Subscribe to:
POZ magazine
E-newsletters
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » May 2008

Web Exclusives

Run This Town

A Voice Against HIV, Malaria and TB

Therapeutic Vaccines: Steady Wins the Race

» More

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

10 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

May 28, 2008

Monitoring Board Finds HIV Combo Inferior

A monitoring board for an international trial comparing three antiretroviral (ARV) regimens has found that Reyataz (atazanavir) combined with Emtriva (emtricitabine) and Videx-EC (didanosine) is inferior to the others studied in terms of viral control. The board has ordered that patients receiving the once-daily Reyataz-based regimen be switched to another drug combination in consultation with their health care provider.

All clinical studies have a Data and Safety Monitoring Board (DSMB) that regularly evaluates the accumulating data to ensure the safety of the participants. In this case, the DSMB was evaluating data from AIDS Clinical Trials Group (ACTG) study 5175, comparing the Reyataz-based regimen to two Sustiva (efavirenz)-based regimens that included either Combivir (zidovudine plus lamivudine) or Truvada (emtricitabine and tenofovir).

According to the DSMB, of the 1,500-patient ACTG trial, people on the Reyataz-based regimen were significantly less likely to have control of their HIV than people taking the other two regimens. For this reason, all people on the problem regimen have now been alerted to the fact and will be switched to an alternative regimen.

In the United States and other industrialized nations, Reyataz is frequently used with low-dose Norvir (ritonavir) to boost its effectiveness.

Search: DSMB, ACTG, 5175, Reyataz, atazanavir, Emtriva, emtricitabine, Videx, didanosine, Combivir, zidovudine, lamivudine, Truvada, tenofovir, Norvir, ritonavir


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

  comments 1 - 2 (of 2 total)    

Marcos, SP, Brazil, 2008-05-30 07:58:19
Hi Michael, A relationship with your doctor based on confidence should exist. If you have doubts about it, I strongly advice you to try other doctor? I did it and didn´t regret so far.

Michael, Plano, 2008-05-29 15:56:23
I found the article on Reyataz combo therapy troublesome. I just started the norvir boosted regimen with Truvada and have felt ill and tired ever since. My doctor gave me no other options and am concerned especially due to history of heart disease in the family as well as my own history. He's suppose to be the best in Dallas but I can't seem to get through to him that I'm not happy about this cocktail and he chalks my fatigue up to low tcells, even though I felt great before. Any advice?

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Community
Advocacy
Job Listings
Events Calendar
Starting Treatment
My Cool Tools


    jspeed
    Dillwyn
    Virginia


    plyn80
    Scottsdale
    Arizona


    speedy143
    queens
    New York


    fun4charlie2
    Orlando
    Florida
Click here to join POZ Personals!
Talk to Us
Poll
Question: Do young people see the HIV/AIDS epidemic as a serious threat?
Yes
No

Survey
It's A Girl Thing

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2009 Smart + Strong. All Rights Reserved. Terms of use and Your privacy